Autolus Therapeutics PLC (AUTL)
4.40
+0.33
(+8.11%)
USD |
NASDAQ |
May 17, 16:00
4.40
0.00 (0.00%)
Pre-Market: 20:00
Autolus Therapeutics Shares Outstanding: 265.93M for March 20, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 20, 2024 | 265.93M |
February 12, 2024 | 232.43M |
December 31, 2023 | 174.10M |
November 09, 2023 | 173.99M |
September 30, 2023 | 173.94M |
June 30, 2023 | 173.68M |
May 31, 2023 | 173.69M |
March 31, 2023 | 173.07M |
March 01, 2023 | 173.07M |
December 31, 2022 | 173.07M |
December 21, 2022 | 173.06M |
December 13, 2022 | 166.13M |
September 30, 2022 | 91.13M |
June 30, 2022 | 90.91M |
May 27, 2022 | 90.92M |
March 31, 2022 | 90.91M |
March 01, 2022 | 90.91M |
December 31, 2021 | 90.91M |
September 30, 2021 | 72.92M |
June 30, 2021 | 72.74M |
May 17, 2021 | 70.58M |
March 31, 2021 | 70.52M |
Date | Value |
---|---|
February 12, 2021 | 70.51M |
January 31, 2021 | 54.02M |
December 31, 2020 | 52.35M |
September 30, 2020 | 52.30M |
June 30, 2020 | 52.25M |
May 15, 2020 | 52.25M |
March 31, 2020 | 52.25M |
January 31, 2020 | 52.23M |
January 27, 2020 | 52.23M |
December 31, 2019 | 44.98M |
September 30, 2019 | 44.98M |
July 15, 2019 | 44.98M |
June 30, 2019 | 44.98M |
April 15, 2019 | 44.98M |
March 31, 2019 | 40.15M |
March 01, 2019 | 40.15M |
December 31, 2018 | 40.15M |
September 30, 2018 | 40.15M |
June 26, 2018 | 40.15M |
June 22, 2018 | 38.79M |
June 08, 2018 | 37.78M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
44.98M
Minimum
Jun 30 2019
265.93M
Maximum
Mar 20 2024
106.54M
Average
90.91M
Median
Dec 31 2021
Shares Outstanding Benchmarks
Adaptimmune Therapeutics PLC | 255.56M |
Biodexa Pharmaceuticals Plc | 4.385M |
NuCana PLC | 2.114M |
TC BioPharm (Holdings) PLC | 3.195M |
Mereo BioPharma Group PLC | 140.27M |